DH241220P17500
- 0.00
- 0.000.00%
Definitive Healthcare Newsroom
BTIG Maintains Definitive Healthcare(DH.US) With Buy Rating, Maintains Target Price $7
A Quick Look at Today's Ratings for Definitive Healthcare(DH.US), With a Forecast Between $5 to $6
Needham Maintains Definitive Healthcare(DH.US) With Hold Rating
Needham Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)
Definitive Healthcare Analyst Ratings
BTIG Initiates Definitive Healthcare(DH.US) With Buy Rating, Announces Target Price $7
Definitive Healthcare Analyst Ratings
Deutsche Bank Maintains Hold on Definitive Healthcare, Lowers Price Target to $5
Definitive Healthcare Price Target Cut to $4.00/Share From $6.00 by Barclays
Definitive Healthcare Analyst Ratings
Baird Maintains Neutral on Definitive Healthcare, Lowers Price Target to $5
Barclays Maintains Definitive Healthcare(DH.US) With Hold Rating, Cuts Target Price to $4
Analysts Offer Insights on Healthcare Companies: Inspire Medical Systems (INSP), Definitive Healthcare Corp (DH) and Bicycle Therapeutics (BCYC)
Goldman Sachs Maintains Definitive Healthcare(DH.US) With Hold Rating, Cuts Target Price to $4
A Quick Look at Today's Ratings for Definitive Healthcare(DH.US), With a Forecast Between $4 to $7.5
Definitive Healthcare Corp: A Balanced Hold Amidst Revenue Forecast Cuts and Strategic Uncertainties
Stifel Nicolaus Reaffirms Their Buy Rating on Definitive Healthcare Corp (DH)
Definitive Healthcare Analyst Ratings
Maintaining Hold Rating for Definitive Healthcare Amidst Downward Financial Revisions and Management Turbulence
Definitive Healthcare Price Target Cut to $6.00/Share From $7.00 by Barclays